These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1588793)

  • 1. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.
    Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K
    Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
    Jernberg H; Pettersson M; Kishimoto T; Nilsson K
    Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
    Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
    Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
    Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors.
    Sidell N; Taga T; Hirano T; Kishimoto T; Saxon A
    J Immunol; 1991 Jun; 146(11):3809-14. PubMed ID: 2033252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
    Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
    Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the in vitro evolution of a myeloma cell line.
    Scibienski RJ; Paglieroni T; Caggiano V; Lemongello D; Gumerlock PH; Mackenzie MR
    Leukemia; 1992 Sep; 6(9):940-7. PubMed ID: 1518305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
    Lasfar A; Wietzerbin J; Billard C
    Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
    Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T
    Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
    Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J; Zheng J; Fang W; Wu B
    Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T; Okuno Y; Ohsugi Y
    Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-6 functions as an autocrine growth stimulator for a human lung adenocarcinoma cell line PAa].
    Fu J; Fang W; Zheng J
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):45-8. PubMed ID: 10743055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
    Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
    Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of interleukin-1 mRNA and interleukin-1 receptors in human B-cell lines.
    Bertoglio J; Dosda J; Stancou R; Wollman E; Fradelizi D
    J Mol Cell Immunol; 1989; 4(3):139-47; discussion 148. PubMed ID: 2527510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
    Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
    Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells.
    Lopez M; Maroc N; Kerangueven F; Bardin F; Courcoul M; Lavezzi C; Birg F; Mannoni P
    Exp Hematol; 1991 Sep; 19(8):797-803. PubMed ID: 1714404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
    Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
    J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.